IPOs not as favored as M&A deals in Q1: Altus Pharmaceuticals' $105 million is largest of first quarter

10 April 2006•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.